Body composition change during neoadjuvant chemotherapy for breast cancer

BACKGROUND: Sarcopenia is receiving attention in oncology as a predictor of increased chemotherapy toxicities. Research into body composition change during neoadjuvant chemotherapy for breast cancer is both urgently needed and generally lacking. This study assessed sarcopenia prevalence before and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Min Kyeong, Park, Seho, Park, Chang, Doorenbos, Ardith Z., Go, Jieon, Kim, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458921/
https://www.ncbi.nlm.nih.gov/pubmed/36091109
http://dx.doi.org/10.3389/fonc.2022.941496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458921/
https://www.ncbi.nlm.nih.gov/pubmed/36091109
http://dx.doi.org/10.3389/fonc.2022.941496

Ejemplares similares